Cortek, Inc., is a privately held company, located in Dedham, Massachusetts. They develop innovative advanced proprietary technologies for the treatment of degenerative disc disease. The Company’s primary goal is to improve patient outcomes by developing products that utilize both static and dynamic spacing solutions for disc disease associated with the lumbar and cervical spine.
Cortek’s 6 main products are the CorLok, Solo, and Duet Lumbar Allograft Systems, the Coreograft PLIF System, the Solo and Connect™ Cervical Allograft Systems. Key product characteristics are as follows: an anterior cortical surface that maximizes compressive strength, dense cancellous bone which allows immediate perfusion and rapid healing, and precise angulation which reestablishes sagittal alignment. The products’ range of sizes provides optimal distraction, and the graft-to-host bone surface area contact promotes excellent healing. Additionally, the fact that it is a fresh frozen implant ensures optimal mechanical strength and consistent sizing. The company offers various allograft products for the ALIF, PLIF and cervical markets.